HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Cambridge Antibody Technology, of Cambridge, UK, part of London-based AstraZeneca plc, and Philochem AG, of Zurich, Switzerland, signed a technology evaluation agreement for Philochem to apply its DNA-encoded libraries to the discovery of low molecular weight compounds against three undisclosed...
-
BioWorld International; Apr 18, 2007; 618 Words
Cambridge Antibody Technology, of Cambridge, UK, part of London-based AstraZeneca plc, and Philochem AG, of Zurich, Switzerland, signed a technology evaluation agreement for Philochem to apply its DNA-encoded libraries to the...
-
-
Schering AG and AstraZeneca Announce Collaboration and Licensing Agreement in the Area of Anti-Inflammatory Agents.
-
PR Newswire; Jul 27, 2005; 700+ Words
...FirstCall/ -- Schering AG, Germany (FSE: SCH, NYSE: SHR) and AstraZeneca today announced that...agents. Schering AG possesses an advanced...areas. Schering and AstraZeneca will undertake a...CONTACT: Schering AG Corporate Communication...schering.de, AstraZeneca: Media Relations...
-
-
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug.
-
PR Newswire; Sep 15, 2006; 700+ Words
...FirstCall/ -- Schering AG, Germany (FSE: SCH, NYSE: SHR) and AstraZeneca have formed an alliance to...jointly commercialize Schering AG's novel SERD. Under the...develop the novel SERD with AstraZeneca leading the clinical development...
-
-
Novartis AG and AstraZeneca PLC.(new company to be called Syngenta AG)(Brief Article)
-
The Food Institute Report; Nov 13, 2000; 700+ Words
* Novartis AG and AstraZeneca PLC are combining their agricultural chemical businesses into a new company to be called Syngenta AG. It will be based in Switzerland and have estimated sales of $8 billion... Wall Street Journal (Nov. 2)
-
-
AstraZeneca forms collaboration with BioVisioN AG.(Brief Article)
-
Nordic Business Report; Oct 8, 2003; 700+ Words
...BUSINESS REPORT-8 October 2003-AstraZeneca forms collaboration with BioVisioN AG(C)1994-2003 M2 COMMUNICATIONS...Swedish pharmaceutical group AstraZeneca has signed a collaboration...biotechnology company BioVisioN AG. The collaboration will focus...
-
-
.... The Federal Trade Commission FTC has given its approval for Novartis AG and AstraZeneca PLC.(Brief Article)
-
The Food Institute Report; Nov 6, 2000; 700+ Words
...Trade Commission FTC has given its approval for Novartis AG and AstraZeneca PLC to combine their agricultural chemical businesses into a new company called Syngenta AG. The new company, according to The Wall Street Journal...
-
-
Fights over patents keep courts busy.(RX RETAIL PHARMACY: Special Report)(Apotex Inc.,AstraZeneca PLC,Forest Laboratories Inc.,Novartis AG, Teva Pharmaceutical Industries Ltd.)
-
Chain Drug Review; Feb 4, 2008; 700+ Words
...represents a further blow for AstraZeneca, which is already fighting...filing its legal action, AstraZeneca has triggered a delay of any...unenforceable. Among companies that AstraZeneca notes have made the challenges...the Sandoz unit of Novartis AG. Separately, Forest Laboratories...
-
-
Bristol-Myers Squibb Co. (New York), Swiss drugmaker Novartis AG and U.K.-based AstraZeneca Plc should be required to conduct long-term studies of heart risks on their experimental diabetes drugs, a U.S. panel said.(Tracking Washington)(Brief article)
-
MondayMorning; Jul 7, 2008; 700+ Words
Tracking Washington: Bristol-Myers Squibb Co. (New York), Swiss drugmaker Novartis AG and U.K.-based AstraZeneca Plc should be required to conduct long-term studies of heart risks on their experimental diabetes drugs...
-
-
AstraZeneca signs development/licensing deals with Schering AG and Astex.
-
Pharma Marketletter; Aug 1, 2005; 700+ Words
Anglo-Swedish drugmaker AstraZeneca has announced two new discovery...Marketletters passim). AstraZeneca has entered into a research...German drug major Schering AG, which relates to a new class...year alliance state that AstraZeneca obtains an exclusive, global...
-
-
AG-1067 misses Ph III primary endpoint; AstraZeneca may drop AtheroGenics accord.(Brief article)
-
Pharma Marketletter; Mar 26, 2007; 700+ Words
...UK's second-largest drugmaker, AstraZeneca (Marketletter January 9, 2006...shares in Anglo-Swedish drug major AstraZeneca fell 1.8% to L28.28. A full description...license and collaboration agreement, AstraZeneca has a 45-day period in which to decide...
-
-
AstraZeneca Expands Access to Incyte Databases and Becomes the First Subscriber to Incyte's LifeExpress RNA and Protein Expression Database Program.
-
Business Wire; Oct 4, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
AAI Announces Research and Development, Licensing, and Product Cooperation Agreement with AstraZeneca for Major Drug Class.
-
PR Newswire; Nov 1, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
Integration of Newest Global Pharmaceuticals Company Moves Forward; AstraZeneca PLC Celebrates June 1 as a Unified Business.
-
PR Newswire; Jun 1, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
AstraZeneca Submits New Drug Application to FDA for Nexium(TM).
-
PR Newswire; Dec 6, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
AstraZeneca Submits NDA For Atacand HCT(TM).
-
PR Newswire; Dec 21, 1999; 678 Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
AstraZeneca Submits Application to FDA for Heart Failure Treatment for Toprol-XL(R).
-
PR Newswire; Sep 16, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca AG Products and Salick Health Care. In the U.S., AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
Patient Infosystems Announces Agreement With AstraZeneca Disease Management Group.
-
Business Wire; Jun 8, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
CIMA Announces Launch of Zomig rapimelt by AstraZeneca.
-
PR Newswire; Sep 16, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
PharmaNetics Announces Expansion of Collaborative Agreement With Astrazeneca.
-
Business Wire; Dec 21, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
-
-
/C O R R E C T I O N -- AstraZeneca LP/.
-
PR Newswire; Aug 5, 1999; 700+ Words
...services. The U.S. operations of AstraZeneca include AstraZeneca, a business unit of Zeneca Inc., AstraZeneca LP, Zeneca Ag Products and Salick Health Care. In the United States, AstraZeneca is a $7.2 billion bioscience business with approximately...
|
|